Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: Expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties

Current Topics in Microbiology and Immunology

Volumn 211, Issue , 1996, Pages 240-252

  Zent, C ^a   Kim, N ^a   Hiebert, S ^b   Zhang, D E ^c   Tenen, D G ^c   Rowley, J D ^a   Nucifora, G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROMOTER;

CARCINOGENICITY; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; GENE REARRANGEMENT; HUMAN; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CHROMOSOMES, HUMAN, PAIR 3; CLONING, MOLECULAR; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; LEUKEMIA, MYELOID; MICE; MICE, NUDE; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RATS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSLOCATION, GENETIC;

MUS MUSCULUS;

EID: 0030053576     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85232-9_24     Document Type: Article

References (26)

1. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y and Ohki M. (1991) The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a novel gene, AML1. Proc Natl Acad Sci USA: 88 10431-10435
2. Nucifora G, Begy CR, Kobayashi H, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle J, and Rowley JD (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in the (3;21)(q26;q22) translocation. Proc Natl Acad Sci USA 91:4004-4008.
3. Roulston D, Nucifora G, Dietz-Band J, LeBeau MM and Rowley JD [1993] Detection of rare 21q22 translocation breakpoints within the AML1 gene in myeloid neoplasms by fluorescence in situ hybridization. Blood 82 (Suppl. 1): 532a
4. Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimon S, Lasher R, Trujillo J, Rowley JD and Drabkin H (1992) Identification of breakpoints in t(8;21) AML and isolation of a fusion transcript with similarity to Drosophila segmentation gene runt. Blood 80:1825-1831
5. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L and Groner Y. AML1, AML2 and AML3, the human members of the runt domain gene-family: cDNA structure, expression and chromosomal localization. (1994) Genomics 23:425-430
6. Wijmenga C, Speck N A, Dracopoli N C, Lewis A F, Hofker M H and Collins F S (1995) Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-ter. Genomics 26:611-614
7. Nucifora G, Birn D, Espinosa R, LeBeau M, Erickson P, Roulston D, McKeithan TW, Drabkin H and Rowley JD (1993) Involvement of the AML1 gene in the t(3:21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 81:2728-2733
8. Meyers S, Lenny N and Hiebert S. (1995) The t(8:21) fusion protein interferes with AML1B-dependent transcriptional activation. Mol Cell Biol 15:1974-1982
9. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi M, Ohki M, Pepling M and Gergen P. (1993) The Runt domain identifies a new family of heterodimeric transcriptional activators. Trends Genet. 9:338-341
10. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ and Collins FS (1993) Fusion between transcription factor CBFβ/PEBP2β and α myosin heavy chain in acute myeloid leukemia. Science 261:1041-1044
11. Nucifora G and Rowley JDR. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood, in press
12. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD and Gilliland DG. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA, in press.
13. Frank R, Zhang J, Hiebert S, Meyers S and Nimer S (1994) AML1B but not the AML1/ETO fusion protein can transactivate the GM-CSF promoter. Blood 84(Suppl. 1):229a
14. Zhang D-R, Fujioka K-I, Hetherington CJ, Shapiro LH, Look AT and Tenen DG. Identification of a region which directs monocytic activity of the CSF-1 (M-CFS) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol, in press.
15. Gollschalk LR and Leiden JM (1990) Identification and functional characterization of the human T-cell receptor β gene transcriptional enhancer: common nuclear proteins interact with the transcriptional regulatory elements of the T-cell receptor α and β genes. Mol Cell Biol 10:5486-5495
16. Kappes DJ, Browne CP and Tonegawa S (1991) Identification of a T-cell-specific enhancer at the locus encoding T-cell antigen receptor δ chain. Proc Natl Acad Sci USA 88:2204-2208
17. Speck NA, Renjifo B, Golemis E, Fredrickson TN, Hartley JW and Hopkins N (1990) Mutation of the core of adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev 4:233-242
18. Wang S and Speck NA (1992) Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol 12:89-102
19. Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y and Hirai H (1995) Dual functions of the AML1/EVI1 chimeric protein in the mechnism of leukemogenesis in t(3;21) leukemia. Mol Cell Biol 15:2383-2392
20. Rubin CM, Larson RA, Anastasi J, Winter JN, Thangavelu M, Vardiman J, Rowley JD and LeBeau MM (1990) t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76:2594-2599
21. Rubin CM, Larson RA, Bitter MA, Carrino JJ, LeBeau MM, Diaz MO and Rowley JD (1987) Association of a chromosomal translocation with the blast phase of chronic myelogenous leukemia. Blood 70:1338-1344
22. Nucifora G, Begy CR, Erickson P, Drabkin H A and Rowley JD. (1993) The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER-1. Proc Natl Acad Sci USA 90: 7784-7788
23. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa MK, Mano H, Yazaki Y, Ohki M and Hirai H. (1994) Generation of the AML1/EVI1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13:504-510
24. Toczyski DPW and Steitz JA (1991) EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs) EMBO J. 10:459-466
25. Toczyski D, Matera AG, Ward DC and Steitz JA The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes (1994) Proc Natl Acad Sci USA 91:3463-3467
26. Sacchi N, Nisson P, Watkins P, Faustinella F, Wijsman J and Hagemeijer A. (1994) AML1 fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts. Genes Chromosomes Cancer 11:226-231